Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts
Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are. His team at BU recently issued a study highlighting these gaps, and emphasizing the need for companies to better document the impact of their programs.
A Kentucky physician wages his own battle against lung cancer, one house call at a time
Dr. Tony Weaver pulls out of the parking lot at St. Claire Regional Medical Center, a rural hospital in the small town of Morehead, Kentucky. He has a house call to make. Today’s appointment is 20 minutes from town, down a two-lane road with no cellphone reception.
He makes rounds of home visits every other week, seeing six or seven patients each time—a welcome change from the dozens he once rushed through on an average day at a clinic.
We’re proud to announce a new philanthropic partnership with the American Diabetes Association (Association). A collaboration between positiveNRG and NRG’s Human Resources team, our partnership with the Association realizes the positiveNRG pillar of health and wellness with the goal of helping to both prevent and delay diabetes while improving the quality of life for those affected by the disease.
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
Better Hearts Better Cities is an initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Non-communicable diseases (NCDs), including cardiovascular disease, are a growing health crisis with 75% of NCD deaths occurring in low- and middle-income countries; this is compounded by rapid urbanization.
The innovative approach is being tested on three continents: in Mongolia, Senegal, and Brazil.
FOSTER CITY, Calif., May 1, 2017 /3BL Media/ - Gilead Sciences, Inc. today announced that it issued its Year in Review 2016 report, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.
The report focuses on four key areas: giving and access, people, products and environment as well as a financial overview. Highlights include:
In the last five years, he and his team -- who refer to themselves as Climbing for Cancer -- have reached the top of the tallest mountains in nearly all 50 states.
Ward, who retired from the Benton Harbor-based appliance maker [Whirlpool Corporation] almost a year ago, is one of several people who raise money for Relay for Life in an effort to combat cancer. Whirlpool Corp. employees and retirees have been involved in Relay for Life of Berrien County since 1996.
CAMBRIDGE, Mass., April 18, 2017 /3BL Media/ -- PatientsLikeMe and Shire plc have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease. Philip Vickers, PhD, Head of Research and Development for Shire, said working with PatientsLikeMe will help the company overcome some of the traditional challenges inherent in understanding rare diseases.
Across the U.S., there is a significant shortage of medical geneticists. With only one geneticist for every 600,000 individuals, the U.S. has less than half of the genetic workforce it needs. As an issue directly related to our business, we announced a $1.65 million grant to the ACMG Foundation for Genetic and Genomic Medicine. The ACMG Foundation is a non-profit organization that works to attract and fund training for the next generation of medical geneticists and genetic counselors. The Foundation also sponsors important research, and promotes information about medical genetics.